Cited by 693Bone Metabolism and DiseasesRheumatoid Arthritis Research and TherapiesOsteomyelitis and Bone Disorders Research

The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.

Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors.

Open access

Arai, Fumio, Miyamoto, Takeshi, Ohneda, Osamu, Inada, Tomohisa, Sudo, Tetsuo, Brasel, Kenneth, Miyata, Takashi, Anderson, Dirk M., Suda, Toshio·1999·The Journal of Experimental Medicine

DOI 10.1084/jem.190.12.1741PMC PMC2195707

Open this paper in CoChat — free account

Abstract

Osteoclasts are terminally differentiated cells derived from hematopoietic stem cells. However, how their precursor cells diverge from macrophagic lineages is not known. We have identified early and late stages of osteoclastogenesis, in which precursor cells sequentially express c-Fms followed by receptor activator of nuclear factor κB (RANK), and have demonstrated that RANK expression in early-stage of precursor cells (c-Fms+RANK−) was stimulated by macrophage colony-stimulating factor (M-CSF). Although M-CSF and RANKL (ligand) induced commitment of late-stage precursor cells (c-Fms+RANK+) into osteoclasts, even late-stage precursors have the potential to differentiate into macrophages without RANKL. Pretreatment of precursors with M-CSF and delayed addition of RANKL showed that timing of RANK expression and subsequent binding of RANKL are critical for osteoclastogenesis. Thus, the RANK–RANKL system determines the osteoclast differentiation of bipotential precursors in the default pathway of macrophagic differentiation.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1084/jem.190.12.1741

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
Self-citation
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Purification and Characterization of Mouse Hematopoietic Stem Cells
Spangrude, G. J., Heimfeld, S., & Weissman, I. L. (1988) · Science · doi:10.1126/science.2898810 · Cited by 2,908
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Self-citation
The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene
Yoshida, H., Hayashi, S.-I., Kunisada, T., Ogawa, M., Nishikawa, S., Okamura, H., Sudo, T., Shultz, L. D., & Nishikawa, S.-I. (1990) · Nature · doi:10.1038/345442a0 · Cited by 1,789
Self-citation
Bone Marrow, Cytokines, and Bone Remodeling — Emerging Insights into the Pathophysiology of Osteoporosis
Manolagas, S. C., & Jilka, R. L. (1995) · New England Journal of Medicine · doi:10.1056/nejm199502023320506 · Cited by 1,670
Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand.
Hsu, H., Lacey, D. L., Dunstan, C. R., Solovyev, I., Colombero, A., Timms, E., Tan, H.-L., Elliott, G., Kelley, M. J., Sarosi, I., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3540 · Cited by 1,636
TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signalingPreprint
Lomaga, M. A., Yeh, W., Sarosi, I., Duncan, G. S., Furlonger, C. L., Ho, A. P., Morony, S., Capparelli, C., Van, G. Y., Kaufman, S., et al. (1999) · Genes & Development · doi:10.1101/gad.13.8.1015 · Cited by 1,265

Flagged first, then by citations

Show all 54 references

1 of the 54 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

Roodman, 1996, Advances in bone biologythe osteoclast, Endocr. Rev., 17, 308

Sorted by citations

Items 501–600 of 692

A Synthetic Peptide, CK2.3, Inhibits RANKL-Induced Osteoclastogenesis through BMPRIa and ERK Signaling Pathway
Nguyen, J., Kelly, S., Wood, R., Heubel, B. P., & Nohe, A. (2020) · Journal of Developmental Biology · doi:10.3390/jdb8030012 · Cited by 10
Usefulness of ceruloplasmin testing as a screening methodology for geriatric patients with osteoporosis
Karakaş, E., Yetisgin, A., Çadırcı, D., Sezen, H., Altunbaş, R., Kas, F., Demir, M., & Ulaş, T. (2016) · Journal of Physical Therapy Science · doi:10.1589/jpts.28.235 · Cited by 11
TREM-1, a negative regulator of human osteoclastogenesis
Lee, B., Kim, J.-H., Jung, J. H., Kim, T., & Ji, J. D. (2016) · Immunology Letters · doi:10.1016/j.imlet.2016.02.002 · Cited by 10
Opposing roles of hematopoietic-specific small GTPase Rac2 and the guanine nucleotide exchange factor Vav1 in osteoclast differentiation
Kang, I. S., Jang, J. S., & Kim, C. (2020) · Scientific Reports · doi:10.1038/s41598-020-63673-6 · Cited by 10
The Origins of the Osteoclast
Aliprantis, A. O., Charles, J. F., & Nakamura, M. C. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00002-5 · Cited by 9
The Fractalkine‐CX3CR1 Axis Regulates Non‐inflammatory Osteoclastogenesis by Enhancing Precursor Cell Survival
Kuboi, Y., Kuroda, Y., Ohkuro, M., Motoi, S., Tomimori, Y., Yasuda, H., Yasuda, N., Imai, T., & Matsuo, K. (2022) · JBMR Plus · doi:10.1002/jbm4.10680 · Cited by 9
Significance of IL-34 and SDC-1 in the pathogenesis of RA cells and preclinical models
Alzoubi, O., Meyer, A., Gonzalez, T. P., Burgos, A. C., Sweiss, N., Zomorrodi, R. K., & Shahrara, S. (2023) · Clinical Immunology · doi:10.1016/j.clim.2023.109635 · Cited by 9
Attenuation of RANKL-induced Osteoclast Formation via p38-mediated NFATc1 Signaling Pathways by Extract ofEuphorbia LathyrisL
Kang, J., Lim, H., Jeong, J.-E., & Yim, M. (2016) · Journal of Bone Metabolism · doi:10.11005/jbm.2016.23.4.207 · Cited by 9
Protective effect ofRhus vernicifluaStokes extract in an experimental model of post-menopausal osteoporosis
Jeong, J. H., An, J. H., Yang, H., Kim, D. K., Lee, N., Jeong, Y., Na, C.-S., Na, D. S., Dong, M., & Han, S. Y. (2017) · Anatomy & Cell Biology · doi:10.5115/acb.2017.50.3.219 · Cited by 9
Hinokitiol inhibits RANKL-induced osteoclastogenesis in vitro and prevents ovariectomy-induced bone loss in vivo
Wang, Y., Yang, Q., Fu, Z., Sun, P., Zhang, T., Wang, K., Li, X., & Qian, Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107619 · Cited by 9
Regulation of Osteoclast Activity
Baron, R., & Horne, W. C. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_3 · Cited by 9
Communication between the skeletal and immune systems
Lee, S.-H., & Choi, Y. (2015) · Osteoporosis and Sarcopenia · doi:10.1016/j.afos.2015.09.004 · Cited by 9
Basic Aspects of Osteoblast Function
Vrahnas, C., & Sims, N. A. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_1 · Cited by 10
Spectral Analysis of Rat Bone Tissue During Long Antiorthostostatic Hanging and at Introduction of Allogen Hydroxyapatitis
Timchenko, E. V., Timchenko, P. E., Pisareva, E. V., Vlasov, M. Y., Volova, L. T., Frolov, O. О., Fedorova, Y. V., Tikhomirova, G. P., Romanova, D. A., & Daniel, M. A. (2020) · Optics and Spectroscopy · doi:10.1134/s0030400x20070243 · Cited by 9
Origins of Osteoclasts
Galson, D. L., & Roodman, G. D. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10002-0 · Cited by 9
Injections of osteoprotegerin and PMA delay tooth eruption
Wise, G. E., Yao, S., & Liu, D. (2005) · Clinical Anatomy · doi:10.1002/ca.20144 · Cited by 9
CD34 human hematopoietic progenitor cell line, MUTZ-3, differentiates into functional osteoclasts
Ciraci, E., Barisani, D., Parafioriti, A., Formisano, G., Arancia, G., Bottazzo, G., & Berardi, A. C. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.03.003 · Cited by 9
Myeloid-derived suppressor cell-derived osteoclasts with bone resorption capacity in the joints of arthritic SKG mice
Fujikawa, Y., Sendo, S., Peral-Fanjul, A. D., Yamada, H., Uto, K., Yamamoto, Y., Nagamoto, T., Morinobu, A., & Saegusa, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1168323 · Cited by 8
Targeting the osteoporotic bone microenvironment: Mechanistic insight and therapeutic biomaterials for accelerating bone regeneration
Lu, X., Zhang, A., Zhang, C., Guo, D., Li, Z. A., & Xie, D. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.02.024 · Cited by 8
Role of skeletal macrophages in fracture repair: A systematic review
Wan, Z., Shin, L.-Y., Wang, Y.-F., Huang, Z., Dong, Y., Lee, C., Kumta, S. M., & Lee, O. (2020) · Biomedical Reports · doi:10.3892/br.2020.1360 · Cited by 9
Stem Cells in Bone Repair and Regeneration
Berika, M. Y., & El-Hashash, A. H. K. (2022) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x17666220410215357 · Cited by 8
The abortive SARS‐CoV‐2 infection of osteoclast precursors promotes their differentiation into osteoclasts
Sviercz, F. A., Jarmoluk, P., Coto, J. G., Cevallos, C. G., Freiberger, R. N., López, C. A. M., Ennis, I. L., Delpino, M. V., & Quarleri, J. F. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29597 · Cited by 8
Conditional Inactivation of Blimp1 in Adult Mice Promotes Increased Bone Mass
Miyauchi, Y., Miyamoto, H., Yoshida, S., Mori, T., Kanagawa, H., Katsuyama, E., Fujie, A., Wu, H., Hoshi, H., Miyamoto, K., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.356634 · Cited by 8
Self-citation
Rab34 plays a critical role as a bidirectional regulator of osteoclastogenesis
Feng, Y., Tran, M. T., Lu, Y., Htike, K., Okusha, Y., Sogawa, C. A., Eguchi, T., Kadowaki, T., Sakai, E., Tsukuba, T., et al. (2022) · Cell Biochemistry and Function · doi:10.1002/cbf.3691 · Cited by 8
Zika virus infects human osteoclasts and blocks differentiation and bone resorption
Mumtaz, N., Koedam, M., van Leeuwen, J. P. T. M., Koopmans, M., van der Eerden, B. C. J., & Rockx, B. (2022) · Emerging Microbes & Infections · doi:10.1080/22221751.2022.2086069 · Cited by 8
Longitudinal evaluation of Wnt inhibitors and comparison with others serum osteoimmunological biomarkers in osteolytic bone metastasis
Galliera, E., Massaccesi, L., de Benedettis, E., Longhi, E., Toma, D. D., Romanelli, M. M. C., & Banfi, G. (2020) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ab0120-212rr · Cited by 8
Radiation alters osteoclastogenesis by regulating the cytoskeleton and lytic enzymes in RAW 264.7 cells and mouse bone marrow-derived macrophages
Tong, L., Wang, Y., Wang, J., He, F., Zhai, J., Bai, J., & Zhu, G. (2020) · International Journal of Radiation Biology · doi:10.1080/09553002.2020.1798542 · Cited by 8
The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice
Awida, Z., Bachar, A., Saed, H., Gorodov, A., Ben‐Califa, N., Ibrahim, M., Kolomansky, A., Iden, J. A., Visacovsky, L. G., Liron, T., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010055 · Cited by 7
Concomitant induction of SLIT3 and microRNA-218–2 in macrophages by toll-like receptor 4 activation limits osteoclast commitment
Kim, E., Kim, J.-E., Chung, S.-H., Park, J. E., Yoon, D., Min, H.-J., Sung, Y., Lee, S. B., Kim, S. W., & Chang, E. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01226-w · Cited by 7
Tristetraprolin regulates the skeletal phenotype and osteoclastogenic potential through monocytic myeloid‐derived suppressor cells
Zhang, L., Kwack, K. H., Thiyagarajan, R., Mullaney, K. K., Lamb, N. A., Bard, J., Sohn, J., Seldeen, K. L., Arao, Y., Blackshear, P. J., et al. (2023) · The FASEB Journal · doi:10.1096/fj.202301703r · Cited by 7
γ‐Secretase inhibitors suppress IL‐20‐mediated osteoclastogenesis via Notch signalling and are affected by Notch2 in vitro
Yang, B., Fu, C., Wu, Y., Liu, Y., Zhang, Z., Chen, X., Wu, D., Gan, Z., Chen, Z., & Cao, Y. (2022) · Scandinavian Journal of Immunology · doi:10.1111/sji.13169 · Cited by 7
A vitronectin-derived dimeric peptide suppresses osteoclastogenesis by binding to c-Fms and inhibiting M-CSF signaling
Jung, S. Y., & Min, B. (2022) · Experimental Cell Research · doi:10.1016/j.yexcr.2022.113252 · Cited by 7
Circulating osteogenic progenitors and osteoclast precursors are associated with long-term glycemic control, sex steroids, and visceral adipose tissue in men with type 2 diabetes mellitus
Ballato, E., Deepika, F., Prado, M., Russo, V., Fuenmayor, V., Bathina, S., Villareal, D. T., Qualls, C., & Armamento‐Villareal, R. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.936159 · Cited by 7
Benincasa hispida Extract Promotes Proliferation, Differentiation, and Mineralization of MC3T3-E1 Preosteoblasts and Inhibits the Differentiation of RAW 246.7 Osteoclast Precursors
Choi, Y., Yang, J.-M., & Cho, J. (2022) · Applied Sciences · doi:10.3390/app12178849 · Cited by 7
A Vitronectin-Derived Peptide Restores Ovariectomy-Induced Bone Loss by Dual Regulation of Bone Remodeling
Kang, H. K., Park, C. Y., Jung, S. Y., Jo, S. B., & Min, B. (2022) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-022-00486-w · Cited by 7
Bone marrow osteoprogenitors are depleted whereas osteoblasts are expanded independent of the osteogenic vasculature in response to zoledronic acid
Hughes, R., Chen, X., Hunter, K. D., Hobbs, J. K., Holen, I., & Brown, N. J. (2019) · The FASEB Journal · doi:10.1096/fj.201900553rr · Cited by 7
Osteoclast Precursor Cells
Lorenzo, J. A. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-72009-8_10 · Cited by 7
The Biology of Macrophages
Sasmono, R. T., & Hume, D. A. (2014) · ASM Press eBooks · doi:10.1128/9781555817671.ch4 · Cited by 7
Modulation of expression of specific transcription factors involved in the bone microenvironment
Lambertini, E., Penolazzi, L., Tavanti, E., Pocaterra, B., Schincaglia, G. P., Torreggiani, E., Franceschetti, T., Vecchiatini, R., Gambari, R., & Piva, R. (2008) · Institutional Research Information System University of Ferrara (University of Ferrara) · Cited by 7
Trafficking of Osteoclast Precursors
Kikuta, J., Nevius, E., Ishii, M., & Pereira, J. P. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00003-7 · Cited by 6
A Cross-Sectional Study of the Association between Autoantibodies and Qualitative Ultrasound Index of Bone in an Elderly Sample without Clinical Autoimmune Disease
Iseme, R. A., McEvoy, M., Kelly, B. J., Agnew, L. L., Walker, F. R., Boyle, M., & Attia, J. (2018) · Journal of Immunology Research · doi:10.1155/2018/9407971 · Cited by 6
Cellular Contributors to Bone Homeostasis
Rauner, M., Jähn, K., Hemmatian, H., Colditz, J., & Goettsch, C. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-46725-8_16 · Cited by 6
Updating the pathophysiology of arthritic bone destruction: identifying and visualizing pathological osteoclasts in pannus
Hasegawa, T. (2021) · Immunological Medicine · doi:10.1080/25785826.2021.1913883 · Cited by 6
A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Cen, W., Reinert, S., Avci‐Adali, M., Alexander, D., & Umrath, F. (2022) · Journal of Visualized Experiments · doi:10.3791/64016 · Cited by 6
Changes in Metabolism and Mitochondrial Bioenergetics during Polyethylene-Induced Osteoclastogenesis
Hazir, N. S. M., Yahaya, N. H. M., Zawawi, M. S. F., Damanhuri, H. A., Mohamed, N., & Alias, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158331 · Cited by 6
Protaetia brevitarsis Extract Attenuates RANKL-Induced Osteoclastogenesis by Inhibiting the JNK/NF-κB/PLCγ2 Signaling Pathway
Jang, H., Kim, J., Kim, J., Kim, B.-S., Lee, Y., & Bae, J. S. (2023) · Nutrients · doi:10.3390/nu15143193 · Cited by 6
Selective deletion of the receptor for CSF1, c-fms, in osteoclasts results in a high bone mass phenotype, smaller osteoclasts in vivo and an impaired response to an anabolic PTH regimen
Zhu, M., Sun, B., Nevius, E., Kaplan, J. M., Pereira, J. P., & Insogna, K. L. (2021) · PLoS ONE · doi:10.1371/journal.pone.0247199 · Cited by 6
Effect of Menaquinone-4 on Receptor Activator of Nuclear Factor κ B Ligand-Induced Osteoclast Differentiation and Ovariectomy-Induced Bone Loss
Lee, A. S., Sung, M. J., Son, S. J., Han, A.-R., Hong, S. M., & Lee, S. (2023) · Journal of Medicinal Food · doi:10.1089/jmf.2022.k.0078 · Cited by 6
Retrovirus-mediated conditional immortalization and analysis of established cell lines of osteoclast precursor cells
Kawata, S., Suzuki, J., Maruoka, M., Mizutamari, M., Ishida‐Kitagawa, N., Yogo, K., Jat, P., & Shishido, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.09.020 · Cited by 6
Effect of Lead Nanoparticles Inhalation on Bone Calcium Sensing Receptor, Hydroxyapatite Crystal and Receptor Activator of Nuclear Factor-Kappa B in Rats
Leonas, R., Noor, Z., Rasyid, H. N., Madjid, T. H., & Tanjung, F. (2016) · Acta Informatica Medica · doi:10.5455/aim.2016.24.343-346 · Cited by 6
Macrophage colony‐stimulating factor pretreatment of bone marrow progenitor cells regulates osteoclast differentiation based upon the stage of myeloid development
Yang, X., Pande, S., Scott, C., & Friesel, R. E. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28512 · Cited by 6
Crebanine protects against ovariectomy-induced bone loss by targeting Sirt1 to interfere with NF-κB acetylation and ROS activity
Zhang, H., Zhao, X., Wang, Z., Miao, J., Hu, X., Cui, P., Jin, C., Zhao, X., Liang, H., Ye, H., et al. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101426 · Cited by 5
CSF1R+ macrophage and osteoclast depletion impairs neural crest proliferation and craniofacial morphogenesis
Ma, F., Zhou, R., Rosin, M., Zhou, I., Ownsworth, S., Memar, R. O., Wong, V. B., & Rosin, J. M. (2026) · Development · doi:10.1242/dev.205423 · Cited by 5
RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial
Link, T., Blohmer, J., Schmitt, W., Kuhlmann, J. D., Just, M., Untch, M., Stötzer, O. J., Fasching, P. A., Thill, M., Reinisch, M., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-1801 · Cited by 5
Emerging Roles of Eosinophils in Bone
Andreev, D., & Porschitz, P. (2025) · Current Osteoporosis Reports · doi:10.1007/s11914-025-00913-6 · Cited by 5
Downregulation of miR-21 gene expression by CRE-Ter to modulate osteoclastogenesis: De Novo mechanism
Pengjam, Y., Prajantasen, T., Tonwong, N., & Panichayupakaranant, P. (2021) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.101002 · Cited by 5
Osteoclast differentiation and dynamic mRNA expression during mice embryonic palatal bone development
Lai, Y., Guo, Y., Liao, C., Mao, C., Liu, J., Ren, C., Yang, W., Luo, L., & Chen, W. (2023) · Scientific Reports · doi:10.1038/s41598-023-42423-4 · Cited by 5
Genetics and Mutations Affecting Osteoclast Development and Function
Horowitz, M. C., Kacena, M. A., & Lorenzo, J. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_6 · Cited by 5
A Novel in vivo Gene Transfer Technique and in vitro Cell Based Assays for the Study of Bone Loss in Musculoskeletal Disorders
Wu, D. J., Dixit, N., Suzuki, É., Nguyen, T. H., Shin, H. S., Davis, J., Maverakis, E. M., & Adamopoulos, I. E. (2014) · Journal of Visualized Experiments · doi:10.3791/51810 · Cited by 5
Osteoclastos: mucho más que células remodeladoras del hueso
Arboleya, L. R., & Castañeda, S. (2014) · Revista de Osteoporosis y Metabolismo Mineral · doi:10.4321/s1889-836x2014000400007 · Cited by 5
1α,25-Dihydroxyvitamin D3 inhibits the differentiation and bone resorption by osteoclasts generated from Wistar rat bone marrow-derived macrophages
Wang, D., Gu, J., CHEN, Y., ZHAO, H.-Y., Liu, W., Song, R., Bian, J., Liu, X., Yuan, Y., & Liu, Z. P. (2015) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2015.2632 · Cited by 5
The Impact of Rheumatic Diseases and Their Treatment on Bone Strength Development in Childhood
Cimaz, R., & Ward, L. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-323-24145-8.00053-3 · Cited by 5
Specification of Sprouty2 functions in osteogenesis in in vivo context
Veselá, B., Švandová, E., Hovořáková, M., Peterková, R., Kratochvílová, A., Pasovská, M., Ramešová, A., Lesot, H., & Matalová, E. (2019) · Organogenesis · doi:10.1080/15476278.2019.1656995 · Cited by 5
The phosphatidylinositol 3-kinase-mediated production of interferon-β is critical for the lipopolysaccharide inhibition of osteoclastogenesis
Lee, Y., Huang, H., Kim, H. J., Park, C.-K., & Kim, H. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.07.002 · Cited by 5
The PDGFR Receptor Family
Chiţu, V., Caescu, C. I., Stanley, E. R., Lennartsson, J., Rönnstrand, L., & Heldin, C. (2015) · Springer eBooks · doi:10.1007/978-3-319-11888-8_10 · Cited by 5
Administration of SB239063 Ameliorates Ovariectomy-Induced Bone Loss via Suppressing Osteoclastogenesis in Mice
Huang, B. H., Wang, J., Zhang, X., Xie, Z., Wu, H., Liu, J., Jie, Z., Zhao, X., Qin, A., Fan, S., et al. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00900 · Cited by 5
Nuclear receptors in osteoclasts
Bae, S., Zeng, S. L., & Park‐Min, K. (2020) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2020.03.002 · Cited by 5
Differentiation of Cells Isolated from Human Femoral Heads into Functional Osteoclasts
Halloran, D. R., Heubel, B. P., MacMurray, C., Root, D., Eskander, M. S., McTague, S., Pelkey, H., & Nohe, A. (2022) · Journal of Developmental Biology · doi:10.3390/jdb10010006 · Cited by 5
Role of RANKL in the regulation of NFATc1 and c-Src mRNA expression in osteoclast-like cells
Fu, J., TAO, Y. D., Chen, J., Zhang, Y., & He, J. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5176 · Cited by 5
Cells Involved in Mechanotransduction Including Mesenchymal Stem Cells
Zuckerman, P. C., Liu, C., & Castillo, A. B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11209-7 · Cited by 5
Periodontitis as a Model for Inflammatory Uncoupling of Bone Remodeling
de Molon, R. S., Tetradis, S., Vernal, R., Leite, F. R. M., & Dyke, T. E. V. (2026) · Journal of Periodontal Research · doi:10.1111/jre.70148 · Cited by 5
Spontaneous Osteoclastogenesis, a risk factor for bone metastasis in advanced luminal A-type breast cancer patients
Vallone, V. B. F., Borzone, F. R., Martinez, L. M., Giorello, M. B., Choi, H., Dimase, F., Feldman, L. J., Bordenave, R. H., Chudzinski‐Tavassi, A. M., Batagelj, E., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1073793 · Cited by 5
Bone and Extracellular Signal-Related Kinase 5 (ERK5)
Wen, L., Liu, Z., Zhou, L., Liu, Z., Li, Q., Geng, B., & Xia, Y. (2024) · Biomolecules · doi:10.3390/biom14050556 · Cited by 4
Strategies for the Codelivery of Osteoclasts and Mesenchymal Stem Cells in 3D-Printable Osteochondral Scaffolds
Jabari, E., Choe, R. H., Kuzemchak, B. C., Venable-Croft, A., Choi, J. Y., McLoughlin, S. T., Packer, J. D., & Fisher, J. P. (2024) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2024.0162 · Cited by 4
hFcγRIIa: a double-edged sword in osteoclastogenesis and bone balance in transgenic mice
Miao, J., Wang, H.-M., Pan, X.-H., Gong, Z., Gao, X., & Gong, F. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425670 · Cited by 4
Association between lipid accumulation products and mortality outcomes in patients with osteoporosis and osteopenia
Liu, Y., Yang, Y., Li, Y., Ding, W., & Yang, X. (2025) · Experimental Gerontology · doi:10.1016/j.exger.2025.112705 · Cited by 4
Bone disease and cytokines in idiopathic hypercalciuria: a review
dos Santos, A. C. S., Lima, E. M., OLIVEIRA, E. A., & Silva, A. C. S. E. (2011) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem.2011.243 · Cited by 4
In vitro osteoclastogenesis in autoimmune diseases – Strengths and pitfalls of a tool for studying pathological bone resorption and other disease characteristics
Škubica, P., Hušáková, M., & Daňková, P. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e21925 · Cited by 4
Bone: Functions, Structure and Physiology
Reis, J. D. C., & Oliveira, M. T. (2020) · Lecture notes in computational vision and biomechanics · doi:10.1007/978-3-030-37541-6_1 · Cited by 4
DAPT inhibits titanium particle‐induced osteolysis by suppressing the RANKL/Notch2 signaling pathway
Wei, X., Fan, B., Chen, X., Cheng, Y., Zhang, A., Yu, S., Zhang, S., & Zhao, H. (2020) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.36972 · Cited by 4
Elevated Gα11expression in osteoblast lineage cells promotes osteoclastogenesis and leads to enhanced trabecular bone accrual in response to pamidronate
Cruz, A. D., Grynpas, M. D., & Mitchell, J. (2016) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00049.2016 · Cited by 4
Dok-3 and Dok-1/-2 adaptors play distinctive roles in cell fusion and proliferation during osteoclastogenesis and cooperatively protect mice from osteopenia
Kajikawa, S., Taguchi, Y., Hayata, T., Ezura, Y., Ueta, R., Arimura, S., Inoue, J., Noda, M., & Yamanashi, Y. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.03.090 · Cited by 4
Determination of NF-κB and RANKL levels in peripheral blood osteoclast precursor cells in chronic kidney disease patients
Güneş, G., Ünal, N., Eskandari, G., KIYKIM, A. A., Çımen, Ö. B., Temel, G. Ö., & ÇİMEN, M. B. Y. (2018) · International Urology and Nephrology · doi:10.1007/s11255-018-1859-0 · Cited by 4
The Effects of Immune Cell Products (Cytokines and Hematopoietic Cell Growth Factors) on Bone Cells
Lorenzo, J. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375670-1.10007-x · Cited by 4
Osteoimmunology: The effect of autoimmunity on fracture healing and skeletal analysis
Lončar, S. R., Halcrow, S. E., & Swales, D. (2023) · Forensic Science International: Synergy · doi:10.1016/j.fsisyn.2023.100326 · Cited by 3
From Development, Disease, and Decline: A Review of What Defines an Osteoclast Progenitor
Shimak, M. J., Kim, G., Karkache, I. Y., Vu, E. K., Chavez, E., Manser, J. C., Patterson, E. S., Basak, A., Vu, K. L., Mitchell, S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110619 · Cited by 3
Iris Koreana NAKAI Inhibits Osteoclast Formation via p38-Mediated Nuclear Factor of Activated T Cells 1 Signaling Pathway
Lee, H.-Y., Jung, J., & Yim, M. (2023) · Journal of Bone Metabolism · doi:10.11005/jbm.2023.30.3.253 · Cited by 3
Early Growth Response 1 Plays an Essential Role in Proinflammatory and Osteoclastogenic Activities of Lipopolysaccharide‐Stimulated Osteoblasts
Yutoku, M., Fujita, K., Chiba, N., Tada, R., Ohnishi, T., Sugimura, M., & Matsuguchi, T. (2025) · The FASEB Journal · doi:10.1096/fj.202402623r · Cited by 3
Effect of The Receptor Activator of Nuclear Factor кB and RANK Ligand on In Vitro Differentiation of Cord Blood CD133(+) Hematopoietic Stem Cells to Osteoclasts.
Kalantari, N., Abroun, S., Soleimani, M., Kaviani, S., Azad, M., Eskandari, F., & Habibi, H. (2016) · PubMed Central · doi:10.22074/cellj.2016.4559 · Cited by 3
Bone—From macrophage to osteoclast and osteolytic diseases
Ramos‐Junior, E. S., Taira, T. M., & Fukada, S. Y. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-821385-8.00011-1 · Cited by 3
Heterologous expression, purification and function of the extracellular domain of human RANK
Wei, Y., Zhan, Y., Chen, P., Liu, Z., Zhang, H., Liu, D., Zhang, J., Yu, M., Mo, W., Zhang, X., et al. (2017) · BMC Biotechnology · doi:10.1186/s12896-017-0405-y · Cited by 3
Phytochemicals in Breast Cancer-Induced Osteoclastogenesis and Bone Resorption: Mechanism and Future Perspective
Pore, S. K., & Hahm, E. (2022) · Current Pharmacology Reports · doi:10.1007/s40495-021-00279-0 · Cited by 3
Anti‑osteoclastogenic effects ofCoriandrum sativum L. via the NF‑κB and ERK‑mediated NFATc1 signaling pathways
Sim, J.-S., Lee, H.-Y., & Yim, M. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12849 · Cited by 3
Molecules Regulating Macrophage Fusions
Miyamoto, T. K., & Suda, T. (2010) · Springer eBooks · doi:10.1007/978-90-481-9772-9_11 · Cited by 3
Self-citation
Prostaglandins and Proinflammatory Cytokines
Raisz, L. G., & Lorenzo, J. (2006) · Elsevier eBooks · doi:10.1016/b9-78-012088-5/62650-008x · Cited by 3
Basic Aspects of Osteoclast Differentiation and Function
Alesi, N., Charles, J. F., & Nakamura, M. C. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_2 · Cited by 3
Cytokines and the Pathogenesis of Osteoporosis
Lorenzo, J. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-415853-5.00038-8 · Cited by 3
Bone and Immune Cell Interactions
Boyce, B. F. (2013) · Wiley eBooks · doi:10.1002/9781118453926.ch124 · Cited by 3
Modulation of RANKL and Osteoprotegerin in Adolescents Using Orthodontic Forces
Hamman, N. (2010) · doi:10.21007/etd.cghs.2010.0125 · Cited by 3
Osteoclast Cell Lineage: Characteristics and Behavior of Osteoclast Precursors In Vivo
Takahashi, N., Mizoguchi, T., Nakamichi, Y., Kobayashi, Y., Nakamura, M., Udagawa, N., & Hofstetter, W. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-814081-9.00222-3 · Cited by 3

Authors: Arai, F., Miyamoto, T., Ohneda, O., Inada, T., Sudo, T., Brasel, K., Miyata, T., Anderson, D. M., & Suda, T.
Affiliations: Meikai University (JP)
Institute of Molecular Embryology and Genetics, Kumamoto University (JP)
Toray Industries, Inc. (Japan) (JP)
dDepartment of Molecular Biology, Immunex Corporation, Seattle, Washington 98101-2936
ORCID: Arai, Fumio
Miyamoto, Takeshi
Ohneda, Osamu
Miyata, Takashi
Anderson, Dirk M.
Suda, Toshio
Venue: The Journal of Experimental Medicine
Publisher: Rockefeller University Press
Published: 1999-12-20
Volume: 190
Issue: 12
Pages: 1741-1754
ISSN: 0022-1007 (ISSN-L)
1540-9538
DOI: 10.1084/jem.190.12.1741
PMC: PMC2195707
OpenAlex: W2132408993
Cited by: 693
References: 54
Citations by year: 2026: 6 · 2025: 16 · 2024: 20 · 2023: 33 · 2022: 33 · 2021: 32 · 2020: 42 · 2019: 38 · 2018: 31 · 2017: 31 · 2016: 30 · 2015: 40 · 2014: 34 · 2013: 31 · 2012: 38
FWCI: 4.13
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: cc-by-nc-sa
Locations: The Journal of Experimental Medicine (publishedVersion)
PubMed Central (publishedVersion, cc-by-nc-sa)
PubMed (publishedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
Health Sciences › Medicine › Rheumatology › Osteomyelitis and Bone Disorders Research
Keywords: osteoclastogenesis, osteoclast precursor cells, c-fms, RANK, RANKL, macrophage colony-stimulating factor, macrophage differentiation, lineage commitment, hematopoietic stem cells
MeSH terms: Animals, Carrier Proteins, Cell Differentiation, Hematopoietic Stem Cells, Ligands, Macrophages, Membrane Glycoproteins, Mice, Inbred C57BL, Osteoclasts, Macrophage Colony-Stimulating Factor, Receptor, Macrophage Colony-Stimulating Factor, Receptors, Tumor Necrosis Factor, Cell Lineage, Mice, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor κB (RANK) receptors.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks